Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years
The company will also share results in two additional posters for deuruxolitinib
The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
These accolades highlight our unwavering commitment to maintaining the highest safety standards
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Subscribe To Our Newsletter & Stay Updated
